Concepedia

Liu Liang Qin

LL

Statistics

Publications

3

Citations

1.1K

H-Index

3

Active since

2000

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Liu Liang Qin is an author at Alnylam Pharmaceuticals (United States) specializing in apoptosis, gene expression, and apoptosis regulation.

Publications per year

2000–2010

3

Publications

3

Lipid-like materials for low-dose, in vivo gene silencing

Kevin T. Love, Kerry P. Mahon, Christopher G. Levins et al. · Proceedings of the National Academy of Sciences · 2010 · 965 citations · Full text

, , +17

Differential Regulation of Cardiomyocyte Survival and Hypertrophy by MDM2, an E3 Ubiquitin Ligase

Ambrus Tóth, Philip Nickson, Liu Liang Qin et al. · Journal of Biological Chemistry · 2005 · 96 citations · Full text

, , +17

Expression of IGF-II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews

Liu Liang Qin · World Journal of Gastroenterology · 2000 · 14 citations · Full text

, , +15

1–3 of 3